Continuous hyperfractionated accelerated radiotherapy (CHART) using volumetric modulated arc therapy (VMAT) for locally advanced non-small cell lung cancer (NSCLC) - the clinical experience

被引:1
|
作者
Shrimali, R. [1 ]
Sen, P. [1 ]
Arunsingh, M. [1 ]
Mahata, A. [2 ]
Mallick, I. [1 ]
Prasath, S. [2 ]
Achari, R. [1 ]
Chatterjee, S. [1 ]
机构
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
[2] Tata Med Ctr, Kolkata, India
关键词
D O I
10.1016/S0169-5002(16)30138-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
121
引用
收藏
页码:S43 / S44
页数:2
相关论文
共 50 条
  • [41] Continuous Hyperfractionated Accelerated Radiotherapy (CHART) and Non-conventionally Fractionated Radiotherapy in the Treatment of Non-small Cell Lung Cancer: a Review and Consideration of Future Directions
    Hatton, M. Q. F.
    Martin, J. E.
    CLINICAL ONCOLOGY, 2010, 22 (05) : 356 - 364
  • [42] Modified VMAT Plans for Locally Advanced Centrally Located Non-Small Cell Lung Cancer (NSCLC)
    Cheung, Eva Y. W.
    Kwong, Virginia H. Y.
    Chan, Fandy Y. C.
    Cheng, Dominic Y. T.
    Cheng, Janice K. Y.
    Yung, Sapphire H. Y.
    Chan, Kiris T. K.
    Cheung, Kelly T. Y.
    Cheung, Tracy S. W.
    Yiu, Janna C. L.
    LIFE-BASEL, 2021, 11 (10):
  • [43] LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER(NSCLC) IN THE ELDERLY: THE INCA EXPERIENCE
    Domingues, Pedro M.
    Zylberberg, Ricardo
    Castro, Thalita D. M.
    Baldotto, Clarissa
    De Lima Araujo, Luiz Henrique
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S134 - S134
  • [44] Potential Benefits of Volumetric Modulated Arc Therapy to Reduce the Incidence of Grade 2 Radiation Pneumonitis in Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients
    Imano, N.
    Kimura, T.
    Kawahara, D.
    Kubo, K.
    Takeuchi, Y.
    Saito, A.
    Nishibuchi, I.
    Murakami, Y.
    Nagata, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E439 - E439
  • [45] Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial" Reply
    Jiang, GL
    RADIOTHERAPY AND ONCOLOGY, 2005, 74 (01) : 77 - 78
  • [46] Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients
    Imano, Nobuki
    Kimura, Tomoki
    Kawahara, Daisuke
    Nishioka, Riku
    Fukumoto, Wataru
    Kawano, Reo
    Kubo, Katsumaro
    Katsuta, Tsuyoshi
    Takeuchi, Yuki
    Nishibuchi, Ikuno
    Murakami, Yuji
    Horimasu, Yasushi
    Masuda, Takeshi
    Fujitaka, Kazunori
    Hattori, Noboru
    Nagata, Yasushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1729 - 1735
  • [47] Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART)
    Jenkins, P
    D'Amico, K
    Benstead, K
    Elyan, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02): : 360 - 366
  • [48] Continuous hyperfractionated accelerated therapy in non-small-cell lung cancer
    Wurschmidt, F
    Heilmann, HP
    LANCET, 1997, 350 (9081): : 888 - 888
  • [49] Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer
    Ferris, Matthew J.
    Martin, Katherine S.
    Switchenko, Jeffrey M.
    Kayode, Oluwatosin A.
    Wolf, Jonathan
    Dang, Quang
    Press, Robert H.
    Curran, Walter J.
    Higgins, Kristin A.
    PRACTICAL RADIATION ONCOLOGY, 2019, 9 (05) : E473 - E481
  • [50] Individualized high-dose continuous hyperfractionated, accelerated radiotherapy (HI-chart) of non-small cell lung cancer (NSCLC) based on normal tissue constraints: a prospective clinical trial
    Van Baardwijk, A.
    Boersma, L.
    Wanders, R.
    Dingemans, A.
    Bootsma, G.
    Geraedts, W.
    Pitz, C.
    Simons, J.
    Lambin, P.
    De Ruysscher, D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 371 - 371